Point72 Asia (Singapore) Pte. Ltd. Mannkind Corp Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $480 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding MNKD
# of Institutions
220Shares Held
133MCall Options Held
1.43MPut Options Held
851K-
Black Rock Inc. New York, NY22.6MShares$146 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$100 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY10.1MShares$65.4 Million5.97% of portfolio
-
State Street Corp Boston, MA9.56MShares$62 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.76MShares$56.8 Million0.62% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.67B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...